Clinical Brief Notes
Researchers may be closer to an Ebola vaccine as two vaccines showed promise in a recent clinical trial (JAMA 2016;315:1610-1623).
The DPP-4 inhibitors saxagliptin and sitagliptin do not increase the risk for heart failure relative to other diabetes medications (Ann Intern Med published online April 26, 2016. doi:10.7326/M15-2568).
Metformin is still a first-line therapy for type 2 diabetes mellitus as monotherapy or combination therapy because of its safety and beneficial effects, based on the findings of a large meta-analysis (Ann Intern Med published online April 19, 2016. doi: 10.7326/M15-2650).
Researchers make progress on Ebola vaccine and diabetes treatments.
Subscribe Now for Access
You have reached your article limit for the month. We hope you found our articles both enjoyable and insightful. For information on new subscriptions, product trials, alternative billing arrangements or group and site discounts please call 800-688-2421. We look forward to having you as a long-term member of the Relias Media community.